| Application number | Title of the application | Filing Date | Status |
|---|
| 09/155983 | USE OF AT LEAST ONE LIPOAMINO ACID AS A SUBSTANCE P ANTAGONIST IN A COSMETIC FORMULATION FOR SOOTHING AND/OR PROTECTING ALL SKIN TYPES, AND IN PARTICULAR SENSITIVE SKIN | Jun 16, 1999 | Abandoned |
Array
(
[id] => 4140658
[patent_doc_number] => 06060450
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Method for treatment of autoimmune diseases'
[patent_app_type] => 1
[patent_app_number] => 9/318202
[patent_app_country] => US
[patent_app_date] => 1999-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 10198
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060450.pdf
[firstpage_image] =>[orig_patent_app_number] => 318202
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/318202 | Method for treatment of autoimmune diseases | May 24, 1999 | Issued |
Array
(
[id] => 1524034
[patent_doc_number] => 06352997
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => 'Method of improving in-vitro fertilization'
[patent_app_type] => B1
[patent_app_number] => 09/303852
[patent_app_country] => US
[patent_app_date] => 1999-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10155
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 971
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/352/06352997.pdf
[firstpage_image] =>[orig_patent_app_number] => 09303852
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/303852 | Method of improving in-vitro fertilization | May 2, 1999 | Issued |
| 09/290985 | COMBINATIONS OF BETA3 AGONISTS AND GROWTH HORMONE SECRETAGOGUES | Apr 12, 1999 | Abandoned |
Array
(
[id] => 1441156
[patent_doc_number] => 06335317
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-01
[patent_title] => 'Use of gut-trophic growth factors to improve oxidative status'
[patent_app_type] => B1
[patent_app_number] => 09/289259
[patent_app_country] => US
[patent_app_date] => 1999-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 8452
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/335/06335317.pdf
[firstpage_image] =>[orig_patent_app_number] => 09289259
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/289259 | Use of gut-trophic growth factors to improve oxidative status | Apr 8, 1999 | Issued |
Array
(
[id] => 4286354
[patent_doc_number] => 06180096
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-30
[patent_title] => 'Formulations for protection of peg-interferon alpha conjugates'
[patent_app_type] => 1
[patent_app_number] => 9/268423
[patent_app_country] => US
[patent_app_date] => 1999-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3276
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/180/06180096.pdf
[firstpage_image] =>[orig_patent_app_number] => 268423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/268423 | Formulations for protection of peg-interferon alpha conjugates | Mar 11, 1999 | Issued |
Array
(
[id] => 4158508
[patent_doc_number] => 06107489
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Extended lifetimes in vivo renin inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/267274
[patent_app_country] => US
[patent_app_date] => 1999-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 8413
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/107/06107489.pdf
[firstpage_image] =>[orig_patent_app_number] => 267274
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/267274 | Extended lifetimes in vivo renin inhibitors | Mar 11, 1999 | Issued |
| 09/254522 | PEPTIDE PRODRUGS CONTAINING AN ALPHA-HYDROXYACID LINKER | Mar 7, 1999 | Abandoned |
Array
(
[id] => 4086969
[patent_doc_number] => 06017886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Use of NDF peptide as growth factor for sensory epithelium'
[patent_app_type] => 1
[patent_app_number] => 9/255974
[patent_app_country] => US
[patent_app_date] => 1999-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5436
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017886.pdf
[firstpage_image] =>[orig_patent_app_number] => 255974
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/255974 | Use of NDF peptide as growth factor for sensory epithelium | Feb 22, 1999 | Issued |
Array
(
[id] => 4297975
[patent_doc_number] => 06197926
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Methods for treatment of diabetes using peptide analogues of insulin'
[patent_app_type] => 1
[patent_app_number] => 9/255668
[patent_app_country] => US
[patent_app_date] => 1999-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 30
[patent_no_of_words] => 9037
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197926.pdf
[firstpage_image] =>[orig_patent_app_number] => 255668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/255668 | Methods for treatment of diabetes using peptide analogues of insulin | Feb 22, 1999 | Issued |
Array
(
[id] => 1536374
[patent_doc_number] => 06337318
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Sustained GnRH peptide-release formulation'
[patent_app_type] => B1
[patent_app_number] => 09/242635
[patent_app_country] => US
[patent_app_date] => 1999-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4682
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337318.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242635
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242635 | Sustained GnRH peptide-release formulation | Feb 18, 1999 | Issued |
| 09/251734 | NOVEL AMIDE DERIVATIVES AS GROWTH HORMONE SECRETAGOGUES | Feb 17, 1999 | Abandoned |
Array
(
[id] => 4287950
[patent_doc_number] => 06211152
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Formulations for peptide release'
[patent_app_type] => 1
[patent_app_number] => 9/251411
[patent_app_country] => US
[patent_app_date] => 1999-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 3081
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211152.pdf
[firstpage_image] =>[orig_patent_app_number] => 251411
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/251411 | Formulations for peptide release | Feb 16, 1999 | Issued |
Array
(
[id] => 4408575
[patent_doc_number] => 06239105
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Homeopathic preparations of purified growth hormone'
[patent_app_type] => 1
[patent_app_number] => 9/251820
[patent_app_country] => US
[patent_app_date] => 1999-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 9055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239105.pdf
[firstpage_image] =>[orig_patent_app_number] => 251820
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/251820 | Homeopathic preparations of purified growth hormone | Feb 16, 1999 | Issued |
Array
(
[id] => 4337520
[patent_doc_number] => 06333307
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Compounds and method for modulating neurite outgrowth'
[patent_app_type] => 1
[patent_app_number] => 9/250059
[patent_app_country] => US
[patent_app_date] => 1999-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23356
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333307.pdf
[firstpage_image] =>[orig_patent_app_number] => 250059
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/250059 | Compounds and method for modulating neurite outgrowth | Feb 11, 1999 | Issued |
Array
(
[id] => 1550009
[patent_doc_number] => 06346512
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-12
[patent_title] => 'Compounds and methods for modulating cell adhesion'
[patent_app_type] => B1
[patent_app_number] => 09/248074
[patent_app_country] => US
[patent_app_date] => 1999-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 59
[patent_no_of_words] => 38663
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/346/06346512.pdf
[firstpage_image] =>[orig_patent_app_number] => 09248074
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/248074 | Compounds and methods for modulating cell adhesion | Feb 9, 1999 | Issued |
Array
(
[id] => 4322679
[patent_doc_number] => 06331523
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5'
[patent_app_type] => 1
[patent_app_number] => 9/240952
[patent_app_country] => US
[patent_app_date] => 1999-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 19997
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331523.pdf
[firstpage_image] =>[orig_patent_app_number] => 240952
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/240952 | Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 | Jan 28, 1999 | Issued |
Array
(
[id] => 4359318
[patent_doc_number] => 06191115
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'C-terminus modified heptapeptide LHRH analogs'
[patent_app_type] => 1
[patent_app_number] => 9/232425
[patent_app_country] => US
[patent_app_date] => 1999-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14384
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/191/06191115.pdf
[firstpage_image] =>[orig_patent_app_number] => 232425
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/232425 | C-terminus modified heptapeptide LHRH analogs | Jan 14, 1999 | Issued |
Array
(
[id] => 4308170
[patent_doc_number] => 06242040
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Functional sodium chloride compositions'
[patent_app_type] => 1
[patent_app_number] => 9/147523
[patent_app_country] => US
[patent_app_date] => 1999-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2766
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242040.pdf
[firstpage_image] =>[orig_patent_app_number] => 147523
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/147523 | Functional sodium chloride compositions | Jan 13, 1999 | Issued |
Array
(
[id] => 4295167
[patent_doc_number] => 06197746
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Method of using secretin for treating autism'
[patent_app_type] => 1
[patent_app_number] => 9/229208
[patent_app_country] => US
[patent_app_date] => 1999-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2602
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197746.pdf
[firstpage_image] =>[orig_patent_app_number] => 229208
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229208 | Method of using secretin for treating autism | Jan 12, 1999 | Issued |